Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 8/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | TP53 | P04637 | 3/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15313028 | 0.98 | TSHR (0.60) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL3681926 | 0.84 | TSHR (0.41) | TSHRHPGDALDH1A1TDP1 | |
| SCHEMBL3681924 | 0.84 | TSHR (0.41) | TSHRHPGDALDH1A1TDP1 | |
| SCHEMBL2725488 | 0.84 | TSHR (0.41) | TSHRHPGDALDH1A1TDP1 | |
| SCHEMBL28963861 | 0.82 | TSHR (0.53) | TSHRHPGDALDH1A1TP53HIF1A | |
| Potassium Ion SCHEMBL15313031 | 0.81 | TSHR (0.58) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL5052638 | 0.81 | TSHR (0.48) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL10702026 | 0.80 | TSHR (0.47) | TSHRHPGDALDH1A1TP53HIF1A | |
| SCHEMBL11599309 | 0.79 | TSHR (0.66) | TSHRHPGDALDH1A1TP53HIF1A | |
| Methylamine SCHEMBL16970990 | 0.79 | TSHR (0.55) | TSHRHPGDALDH1A1TP53HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111432891-B | Polymer containing phosphonyl-phosphate groups and anionic groups | 宝洁公司 | 2024-01-02 | — | — | CN | claimed |
| CN-114583163-A | Dispersing agent for lithium ion battery, preparation method of dispersing agent, positive electrode slurry, positive plate and lithium ion battery | 比亚迪股份有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-113817883-A | Sulfonate-containing polymer retanning fatliquor and preparation method thereof | 四川亭江新材料股份有限公司 | 2021-12-21 | — | — | CN | claimed |
| US-11198763-B2 | Oral care compositions comprising phosphono-phosphate and anionic group containing polymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-12-14 | — | — | US | claimed |
| US-11008411-B2 | Phosphono-phosphate and anionic group containing polymers | THE PROCTER & GAMBLE COMPANY (US) | 2021-05-18 | — | — | US | claimed |
| EP-3723703-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONATE AND ANIONIC GROUP CONTAINING POLYMERS | The Procter & Gamble Company (US) | 2020-10-21 | — | — | EP | claimed |
| EP-3723865-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | The Procter & Gamble Company (US) | 2020-10-21 | — | — | EP | claimed |
| EP-3723867-A1 | PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | The Procter & Gamble Company (US) | 2020-10-21 | — | — | EP | claimed |
| CN-111465383-A | Oral care compositions comprising polymers containing phosphonate groups and anionic groups | 宝洁公司 | 2020-07-28 | — | — | CN | claimed |
| CN-111447974-A | Oral care compositions comprising polymers containing phosphono-phosphate groups and anionic groups | 宝洁公司 | 2020-07-24 | — | — | CN | claimed |
| CN-111432891-A | Polymers containing phosphono-phosphate groups and anionic groups | 宝洁公司 | 2020-07-17 | — | — | CN | claimed |
| WO-2019118417-A1 | PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2019-06-20 | — | — | WO | claimed |
| WO-2019118414-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2019-06-20 | — | — | WO | claimed |
| WO-2019118415-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY (US) | 2019-06-20 | — | — | WO | claimed |
| US-20190177490-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONO-PHOSPHATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | claimed |
| US-20190175485-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONATE AND ANIONIC GROUP CONTAINING POLYMERS | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | claimed |
| US-20190177451-A1 | Phosphono-Phosphate And Anionic Group Containing Polymers | THE PROCTER & GAMBLE COMPANY | 2019-06-13 | — | — | US | claimed |
| CN-102532560-B | Method for preparing cement dispersing agent based on polyvinyl alcohol Michael addition reaction | UNIV BEIJING TECHNOLOGY | 2013-08-07 | — | — | CN | claimed |
| US-6436878-B1 | COPOLYMER OF ACRYLIC ACID, 2-HYDROXYPROPYL ACRYLATE, N-(4-SULFOPHENYL)-MALEIMIDE, ALLYLTRIMETHYLAMMONIUM CHLORIDE AND APHOSPHOROUS ACID | Wang, Bin (CN) | 2002-08-20 | — | — | US | claimed |
| US-5399616-A | Obtained by polymerization of unsaturated monocarboxylic acid or amide, sulfonated alkyl or aryl monovinyl compound, and, optionally, an N-vinyl amide in presence of fatty acid ester of polyol; textile dyeing or whitening therewith | CIBA-GEIGY CORPORATION (US) | 1995-03-21 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177451-A1 | Phosphono-Phosphate And Anionic Group Containing Polymers | PHOSPHO1, PHPT1, ACP1 | TSHR 3710/4885HPGD 1930/4885ALDH1A1 4855/4885 |
| US-11008411-B2 | Phosphono-phosphate and anionic group containing polymers | PHOSPHO1, PHPT1, ACP1 | TSHR 3710/4885HPGD 1930/4885ALDH1A1 4855/4885 |
| US-20190175485-A1 | ORAL CARE COMPOSITIONS COMPRISING PHOSPHONATE AND ANIONIC GROUP CONTAINING POLYMERS | PHOSPHO1, PHPT1, DSC1 | TSHR 4238/4885HPGD 1940/4885ALDH1A1 4857/4885 |
| US-11198763-B2 | Oral care compositions comprising phosphono-phosphate and anionic group containing polymers | PHOSPHO1, PHPT1, INPP5D | TSHR 4586/4885HPGD 1560/4885ALDH1A1 4870/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.